Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media






Home
Bias Split
Public FiguresControversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!

How our sliders workAboutContact UsNewsletter Archive
MediaFAQGlossaryPrivacy Policy
  1. Home

WH Plans to Increase Access to Paxlovid and 'Test-to-Treat' Sites

  • #Diseases & conditions
  • #Medicine & healthcare
  • #COVID-19
  • #Testing
story
MAY 2022
Image copyright: Pfizer/AP [via USA Today]
story last updated JAN 2023

The Spin

Democratic narrative

Now's the time to prepare for another potential virus surge or outbreak in the future. This means budgetary commitments to strengthen the country's pandemic surveillance system, maintain testing infrastructure, and protect our most vulnerable citizens with boosters, antivirals such as Paxlovid, and other precautions. We need to put financial skin in the game.

CNN

Republican narrative

Democrats can't have it both ways. They can't devote billions to COVID treatments like Paxlovid and preventative measures at the same time they're trying to end the Title 42 immigration policy based on the notion that we're out of the COVID era. Which one is it?

FOX News

Narrative C

It's possible that the "Paxlovid Rebound Effect" is actually a broader "COVID Rebound Effect" and is occurring whether one has the antivirals or not. These cases have reportedly happened throughout the pandemic, but unfortunately there's been little data to date. This gets messy - there are public health pros and cons in asking people isolate if they test positive again.

USA Today

Political split

LEFT

RIGHT

Here’s What Scientists Know About Paxlovid Rebound
TimeJUL 2022
White House touts efforts to expand COVID test-to-treat sites amid latest wave
CBSJUL 2022
With new attempts to deliver Covid pills, the White House says virus deaths should be ‘largely preventable.’
New York TimesJUL 2022
White House to EXPAND use of Pfizer antiviral drug Paxlovid
Daily MailJUL 2022
White House making COVID antiviral drug more available at test sites
New York PostJUL 2022